Gilead buys a molecule from Leo Pharma to treat inflammatory diseases for 1.7 billion
Gilead expands its portfolio and now enters the inflammatory diseases business. The American biotechnology company has purchased the rights to ...
Tag: Gilead
Popular News
-
Trump takes credit for the Gaza ceasefire agreement: “We have achieved so much without even being in the White House”
-
Barcelona – Betis, live: result, goals and last minute online of the Copa del Rey match today
-
Nuclear was the second source of electricity in 2024 but is doomed to closure due to the Government’s rejection and lack of guarantees from the PP
-
What no one tells you: these are the benefits of silicon-enriched meat for type 2 diabetes
-
Six historic ETA leaders will go on trial for the murder of businessman Francisco Arratibel
